id: NEW:post_market_evidence_generation_policy_to_NEW:medical_device_safety_evidence_quality
name: Post-Market Evidence Generation Policy â†’ Medical Device Safety Evidence Quality
from_node:
  node_id: NEW:post_market_evidence_generation_policy
  node_name: Post-Market Evidence Generation Policy
to_node:
  node_id: NEW:medical_device_safety_evidence_quality
  node_name: Medical Device Safety Evidence Quality
direction: positive
category: political
mechanism_pathway:
- 'Step 1: Regulatory policies require conditional approval holders to generate further real-world evidence
  after initial market access'
- 'Step 2: Manufacturers conduct post-market studies to fulfill regulatory commitments'
- 'Step 3: Additional clinical data accumulates on device performance in broader patient populations'
- 'Step 4: Evidence base for device safety and effectiveness is strengthened over time'
evidence:
  quality_rating: B
  n_studies: 8
  primary_citation: '2024. "Regulatory perspectives on post-market evidence generation schemes for high-risk
    medical devices: a systematic review." https://doi.org/10.1080/14737167.2024.2431234'
  supporting_citations:
  - Peer-reviewed literature from Medline database on device approval
  - Peer-reviewed literature from Embase database on conditional approval
  - Gray literature sources on post-market evidence generation
  doi: 10.1080/14737167.2024.2431234
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The review identifies that conditional approval schemes in multiple jurisdictions require
  manufacturers to generate additional evidence after initial market access. This creates a policy mechanism
  whereby devices with promising but incomplete evidence can reach patients while building a stronger
  evidence base over time.
spatial_variation:
  varies_by_geography: true
  variation_notes: Post-market evidence requirements differ between USA (FDA), China (NMPA), Canada, and
    European Notified Bodies approaches
moderators:
- name: enforcement_mechanisms
  direction: strengthens
  strength: moderate
  description: Strength of regulatory enforcement of post-market study commitments affects quality of
    evidence generated
structural_competency:
  equity_implications: This mechanism traces to policy-level decisions about how to balance innovation
    access with evidence requirements. It represents a structural approach to managing uncertainty in
    medical device safety rather than placing burden on individual patients or providers to evaluate incomplete
    evidence.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.434433'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
